Mackenzie Financial’s CTI BioPharma CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-91,714
Closed -$551K – 1650
2022
Q4
$551K Buy
+91,714
New +$501K ﹤0.01% 898

Other funds holding CTIC

Mackenzie Financial's CTIC Position: Q1 2023 in Review

Mackenzie Financial sold out of CTI BioPharma (CTIC) in Q1 2023, closing a stake of 91,714 shares — an estimated $551K sold.

Mackenzie Financial first reported a position in CTIC in Q4 2022 and held it in 1 quarter. The position peaked at $551K in Q4 2022. 132 funds tracked by Wall St. Rank hold CTIC as of Q1 2023.

  • Mackenzie Financial reported no remaining CTI BioPharma position as of Q1 2023 after selling out during the quarter.
  • Mackenzie Financial sold 91,714 CTI BioPharma shares in Q1 2023, an estimated $551K.
  • Mackenzie Financial first reported a position in CTI BioPharma in Q4 2022 and held it in 1 quarter.
  • Mackenzie Financial's CTI BioPharma position peaked at $551K in Q4 2022.
  • 132 funds tracked by Wall St. Rank held CTI BioPharma as of Q1 2023.

Based on Mackenzie Financial's 13F filing for Q1 2023, filed 24 Apr 2023.